We are an important partner to the Slovenian healthcare system with our generic and biosimilar medicines.
Read key business and development news in our company and various activities that we support and co-create. You can also browse the news archives dating back to 1998, our photo library and visual identity. For additional information, you can write to us at info.lek@sandoz.com.
Prof. Zdenko Časar, PhD, Head of Early Stage Development at Lek, has been awarded the Puh Award for his outstanding work in the ...
Sandoz, the global leader in generic and biosimilar medicines, today celebrates the start of share trading on the SIX Swiss Exchange as an independent company.
Yesterday,the Chamber of Commerce and Industry of Slovenia presented awards for the bestinnovations in the country. Atthe Innovation Day held at Brdo ...
Between September 7 and 10, Lek, a Sandoz company, hosted ScienceBEAT, a world-class scientific and professional event aimed at promising natural sciences and business students ...
Contact
Lek d.d.
Verovškova 57, 1526 Ljubljana, Slovenia
T: +386 1 580 21 11
F: +386 1 568 35 17
info.lek@sandoz.com
VAT No.: SI87916452
Registration number: 1732811000
Nominal capital: 48.402.003,00 EUR